Skip to content
HowShorted

IGM Biosciences, Inc. short interest in 2022

In 2022, IGM Biosciences, Inc.'s disclosed short interest ran from 13.20% of shares outstanding on 14 Jan 2022 to 8.10% on 30 Dec 2022, a change of -5.10 percentage points. The year's high was 14.41% on 15 Feb 2022 and its low 6.96% on 15 Jun 2022, averaging 9.74% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 29.79 days on 31 Oct 2022. Full history: IGM Biosciences, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for IGM Biosciences, Inc. in 2022

2022 in figures

Start of year
13.20% (14 Jan 2022)
End of year
8.10% (30 Dec 2022)
Change
-5.10 pp
High
14.41% (15 Feb 2022)
Low
6.96% (15 Jun 2022)
Average
9.74%
Highest days to cover
29.79 (31 Oct 2022)
SEC filings marked
9

Every report in 2022

IGM Biosciences, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202213.20%16.35results (8-K)
31 Jan 202214.10%9.61
15 Feb 202214.41%14.72
28 Feb 202214.19%18.74
15 Mar 202213.96%19.13
31 Mar 202213.50%1.0010-K filed, results (8-K)
14 Apr 202213.29%7.30
29 Apr 202212.08%11.63
13 May 20228.25%8.2910-Q filed, results (8-K)
31 May 20227.73%8.45
15 Jun 20226.96%13.78
30 Jun 20227.26%8.15
15 Jul 20227.71%24.88
29 Jul 20227.80%23.68
15 Aug 20227.61%13.2310-Q filed, results (8-K)
31 Aug 20227.86%17.29
15 Sep 20227.55%17.18
30 Sep 20227.80%13.66
14 Oct 20228.08%22.60
31 Oct 20227.88%29.79
15 Nov 20228.31%10.8610-Q filed, results (8-K)
30 Nov 20227.53%13.12
15 Dec 20228.50%13.88
30 Dec 20228.10%16.49

See also: IGM Biosciences, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.